Continued here:
Artelo Biosciences Files Patent on Use of Fatty Acid Binding Protein 5 Inhibitors for Treating Psychological Disorders

Visit link:
Kinnate Biopharma Inc. to Participate at the Goldman Sachs 42nd Annual Global Healthcare Conference

Continued here:
atai Life Sciences to Participate in Upcoming November Investor Conferences

View post:
Altimmune Begins Multinational Phase 2 Clinical Trial of HepTcellTM, a Novel Immunotherapeutic for the Treatment of Chronic Hepatitis B

See the original post here:
Motus GI Announces Warrant Exercise Agreement Resulting in Expected Gross Proceeds to the Company of up to $11 Million

Read more:
Sio Gene Therapies Announces Positive Six-Month Follow-Up Data from Low-Dose Cohort of Phase 1/2 Trial of AXO-AAV-GM1 for GM1 Gangliosidosis

See the original post:
Arch Biopartners Receives Government of Canada Funding to Support Phase II Therapeutic Trial of Metablok for COVID-19

Here is the original post:
Timber Pharmaceuticals Signs Waiver Agreement with Warrant Holders

The rest is here:
Praxis Precision Medicines to Participate in Upcoming Investor Conferences

500 mg/dL)]]>

Read the rest here:
Amarin Shares Topline Data from Partner’s Pivotal Phase 3 Study of VASCEPA® (Icosapent Ethyl) in Mainland China

Read more:
Chinook Therapeutics to Present at Upcoming Investor Conferences

Continue reading here:
Notice of Extraordinary General Meeting in Immunicum AB (publ)

Read the original:
Capricor Therapeutics to Present Third Quarter 2020 Financial Results and Recent Corporate Update on November 12

Link:
Immutep Announces Expansion of TACTI-002 Collaboration Trial

View post:
Novan Reports Third Quarter 2020 Financial Results and Provides Corporate Update

Read the original here:
Marrone Bio Innovations Appoints Lara L. Lee to Board of Directors

Read the original here:
Medexus Announces Engagement of Westmount Capital and Equity Incentive Grants to Insiders

See original here:
Trevena, Inc. Announces DEA Scheduling of OLINVYK™ (oliceridine) injection

See the original post here:
Myovant Sciences Presents Additional Data on Relugolix Combination Therapy from Studies in Endometriosis and Uterine Fibroids

Read the original post:
SCYNEXIS to Present Data Supporting the Efficacy of Ibrexafungerp Against Invasive Fungal Infections at IDWeek 2020